Enhancing/NN
effect/NN
of/IN
17/CD
beta-estradiol/NN
on/IN
human/JJ
NK/NN
cell/NN
activity/NN
./.

The/DT
in/FW
vitro/FW
effect/NN
of/IN
17/CD
beta-estradiol/NN
on/IN
NK/NN
activity/NN
was/VBD
studied/VBN
./.
=====
The/DT
proliferation/NN
and/CC
NK/NN
activity/NN
of/IN
YT-N17/NN
(/(
a/DT
human/JJ
NK-like/JJ
cell/NN
line/NN
)/)
were/VBD
enhanced/VBN
by/IN
17/CD
beta-estradiol/NN
(/(
E2/NN
)/)
,/,
and/CC
the/DT
enhancement/NN
was/VBD
blocked/VBN
by/IN
tamoxifen/NN
(/(
Tx/NN
)/)
,/,
an/DT
antagonist/NN
of/IN
E2/NN
./.
=====
On/IN
the/DT
contrary/NN
,/,
other/JJ
steroid/NN
hormones/NNS
such/JJ
as/IN
Tx/NN
,/,
progesterone/NN
,/,
and/CC
testosterone/NN
had/VBD
no/DT
effect/NN
./.
=====
YT-N17/NN
contained/VBD
11.8/CD
fmol/mg/NN
protein/NN
of/IN
estrogen/NN
receptor/NN
(/(
mean/NN
of/IN
two/CD
independent/JJ
assays/NNS
)/)
,/,
a/DT
value/NN
which/WDT
was/VBD
5-10-fold/RB
higher/JJR
than/IN
that/DT
of/IN
other/JJ
hematopoietic/JJ
cell/NN
lines/NNS
./.
=====
An/DT
enhancement/NN
of/IN
NK/NN
activity/NN
by/IN
E2/NN
was/VBD
also/RB
seen/VBN
in/IN
large/JJ
granular/JJ
lymphocytes/NNS
obtained/VBN
from/IN
normal/JJ
subjects/NNS
,/,
and/CC
it/PRP
was/VBD
again/RB
suppressed/VBN
by/IN
Tx/NN
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
E2/NN
is/VBZ
one/CD
of/IN
the/DT
activating/VBG
factors/NNS
for/IN
NK/LGL/NN
cells/NNS
./.